Life Sciences Corporate Disputes
Analysis Group provides rigorous economic, financial, and scientific analyses to support clients in complex corporate disputes within the health care and life sciences industries. Our deep industry and subject matter expertise across the life sciences ecosystem enables us to provide rigorous analyses and expert testimony across a wide range of topics to help our clients navigate complex corporate disputes.
We have worked with major pharmaceutical, biotech, and medical device companies, health systems, and insurance providers in high-stakes corporate disputes, including those involving claims of contract breaches, unfair competition, trade secret theft, and intellectual property infringement, among others.
Our Capabilities
Intellectual Property Valuation
Determination of the economic value of patents, proprietary technologies, and licensing agreements in patent and trade secret–related disputes, including cases involving blockbuster drugs, medical devices, and pharmaceutical and biotech innovations (e.g., platform technologies, manufacturing processes) at different stages of development
Contractual Disputes and Supplier Relationships
Evaluation of commercial reasonableness of agreements and allegations of breach of contract (e.g., use of commercially reasonable efforts) in co-development and co-marketing agreements, pricing structures, and supply chain economics among health care and life sciences firms
Damages and Financial Impact
Quantification of lost profits, reasonable royalties, unjust enrichment, and economic harm in high-stakes litigation between companies within the health care and life sciences industries
Tortious Interference and Corporate Raiding
Analysis of allegations of intentional disruptions of contractual or business relationships and improper solicitation of employees or business relationships
Payer/Provider, Claims Handling and Payment, and Pricing/Coverage Disputes
- Analysis of reimbursement structures, contract compliance, and disputes over medical necessity and service payments
- Evaluation of claim administration, denials, and practices and disputes over formulary placement and pricing strategies for pharmaceuticals and medical devices
Our Expert Offerings
Scientific and Technical Experts
Providing in-depth analyses of technologies, research and development processes, clinical trials, efficacy and safety data, and manufacturing issues in disputes involving pharmaceutical and biotech assets and medical devices
Regulatory Experts
Offering insights into regulatory approval and compliance processes in life sciences litigation, including in the US, Europe, and Asia
Licensing and Business Alliance Experts
Analyzing licensing agreements, technology transfers, and revenue/cost-sharing disputes related to life sciences collaborations, including joint ventures and university partnerships
Former Life Sciences Industry Executives
Evaluating strategic, commercial, and operational considerations in disputes involving business practices, partnerships, and competitive conduct, including analyses of the feasibility, costs, and risks associated with pharmaceutical and biotech innovation, investment, and product launches
Intellectual Property Valuation Experts
Assessing the economic value of patents, trademarks, and proprietary technology in litigation and arbitration
Economic and Damages Experts
Providing lost profits, reasonable royalty, and unjust enrichment calculations; competitive analysis; and insights into the economics of innovation
-
Featured Expert Amitabh Chandra -
Case OutcomeNippon Shinyaku Co., Ltd., et al. v. Sarepta Therapeutics, Inc., et al. -
Featured Expert Michael Scott Kinch -
Publishing Economic Considerations Related to Biosimilar Market Entry -
Forum Vaccines, Incentives, and Innovation: The Lessons of COVID-19 for the Pharmaceutical Industry
